An essential role for miR-15/16 in Treg suppression and restriction of proliferation
Year: 2023
Type: article
Abstract: The miR-15/16 family is a highly expressed group of tumor suppressor miRNAs that target a large network of genes in T cells to restrict their cell cycle, memory formation and survival. Upon T cell activation, miR-15/16 are downregulated, allowing rapid expansion of differentiated effector T cells to mediate a sustained immune response. Here, using conditional deletion of miR-15/16 in immunosuppressive regulatory T cells (Tregs) that express FOXP3, we identify new functions of the miR-15/16 family in T cell immunity. miR-15/16 are indispensable to maintain peripheral tolerance by securing efficient suppression by a limited number of Tregs. miR-15/16-deficiency alters Treg expression of critical functional proteins including FOXP3, IL2Rα/CD25, CTLA4, PD-1 and IL7Rα/CD127, and results in accumulation of functionally impaired FOXP3 lo CD25 lo CD127 hi Tregs. Excessive proliferation in the absence of miR-15/16 inhibition of cell cycle programs shifts Treg diversity and produces an effector Treg phenotype characterized by low expression of TCF1, CD25 and CD62L, and high expression of CD44. These Tregs fail to control immune activation of CD4 + effector T cells, leading to spontaneous multi-organ inflammation and increased allergic airway inflammation in a mouse model of asthma. Together, our results demonstrate that miR-15/16 expression in Tregs is essential to maintain immune tolerance. Highlights Treg-specific miR-15/16 expression is essential to prevent systemic tissue inflammation miR-15/16 restrict Treg proliferation and regulate expression of the key functional Treg molecules FOXP3, IL2Rα, CTLA4, PD-1 and IL7Rα miR-15/16 limit formation of effector Tregs and is necessary for high suppressive capacity
Source: Cell Reports
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,460
Funders: Wenner-Gren Foundation, Wenner-Gren Stiftelserna, Riksförbundet HjärtLung, Sweden-America Foundation, Hjärt-Lungfonden, Stiftelsen Blanceflor Boncompagni Ludovisi, född Bildt, National Institutes of Health, University of California, San Francisco, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1059795550, G1239756754, BD FACSAria Fusion Cell Sorter, G453267231, G4756830717, G5351157054, G5393916361, Exploring the biology of persistent type 2 airway niches in asthma, G6990391853, G9000000593, G9000001142, G9000176275, Mentoring Research in Precision Medicine for Lung Disease, MicroRNA directed pathway discovery in allergy and asthma
OpenAlex ID: W4387784023
